These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25633516)
1. 18F-FDG-PET/CT in staging, recurrence detection and response evaluation of primary splenic lymphoma with eight years follow up. Karunanithi S; Roy SG; Murugan V; Bal C; Kumar R Nucl Med Rev Cent East Eur; 2015; 18(1):37-8. PubMed ID: 25633516 [TBL] [Abstract][Full Text] [Related]
2. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas]. Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637 [TBL] [Abstract][Full Text] [Related]
4. The management of pyothorax-associated lymphoma using 18F-FDG PET/CT. Ito K; Shida Y; Kubota K; Morooka M; Aruga T; Itami J; Matsuda H Ann Nucl Med; 2010 Nov; 24(9):649-54. PubMed ID: 20740330 [TBL] [Abstract][Full Text] [Related]
5. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence. Isohashi K; Tatsumi M; Higuchi I; Inoue A; Nakajo K; Ishikawa J; Shimosegawa E; Kanakura Y; Nakamura H; Hatazawa J Ann Nucl Med; 2008 Nov; 22(9):795-802. PubMed ID: 19039558 [TBL] [Abstract][Full Text] [Related]
6. Pediatric presentation of splenic marginal zone lymphoma on FDG PET/CT scan. Rezaee A; Zhao XF; Dilsizian V; Chen W Clin Nucl Med; 2014 Feb; 39(2):178-80. PubMed ID: 23640226 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment. Chiewvit S; Thephamongkhol K; Ubolnuch K; Pooliam J; Phongsawat N; Chiewvit P J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients. Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320 [TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. Rini JN; Leonidas JC; Tomas MB; Palestro CJ J Nucl Med; 2003 Jul; 44(7):1072-4. PubMed ID: 12843223 [TBL] [Abstract][Full Text] [Related]
10. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma. Hagtvedt T; Seierstad T; Lund KV; Løndalen AM; Bogsrud TV; Smith HJ; Geier OM; Holte H; Aaløkken TM Acta Radiol; 2015 Feb; 56(2):152-8. PubMed ID: 24585944 [TBL] [Abstract][Full Text] [Related]
12. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687 [TBL] [Abstract][Full Text] [Related]
13. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma. Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697 [TBL] [Abstract][Full Text] [Related]
14. ¹⁸F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas. Eugene T; Corradini N; Carlier T; Dupas B; Leux C; Bodet-Milin C Nucl Med Commun; 2012 Oct; 33(10):1089-95. PubMed ID: 22929116 [TBL] [Abstract][Full Text] [Related]
15. The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: a retrospective study of 66 scans from a single institution. George A; Girault S; Testard A; Delva R; Soulié P; Couturier OF; Morel O Nucl Med Commun; 2014 Mar; 35(3):282-90. PubMed ID: 24240193 [TBL] [Abstract][Full Text] [Related]
16. FDG PET-CT in the management of primary breast lymphoma. Santra A; Kumar R; Reddy R; Halanaik D; Kumar R; Bal CS; Malhotra A Clin Nucl Med; 2009 Dec; 34(12):848-53. PubMed ID: 20139815 [TBL] [Abstract][Full Text] [Related]
17. Impact of FDG-PET/CT in the management of lymphoma. Baba S; Abe K; Isoda T; Maruoka Y; Sasaki M; Honda H Ann Nucl Med; 2011 Dec; 25(10):701-16. PubMed ID: 22037934 [TBL] [Abstract][Full Text] [Related]
18. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma? van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861 [TBL] [Abstract][Full Text] [Related]
19. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma. Yi JH; Kim SJ; Choi JY; Ko YH; Kim BT; Kim WS Hematol Oncol; 2010 Jun; 28(2):57-61. PubMed ID: 19593742 [TBL] [Abstract][Full Text] [Related]
20. 18F-FDG uptake in multiple splenic foci on PET/CT: an unusual case of visceral leishmaniasis. Gibson GM; Arnold C; Ravi Kumar AS Clin Nucl Med; 2014 Sep; 39(9):828-30. PubMed ID: 24561685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]